Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-002399
Filing Date
2025-03-04
Accepted
2025-03-04 12:36:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27738
2 filename2.txt TEXT-EXTRACT 1249
  Complete submission text file 0000000000-25-002399.txt   40289
Mailing Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830
Business Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filed for) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: UPLOAD | File No.: 333-285438
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)